Pfizer Covid vaccine
Three doses of Pfizer Covid vaccine better than two: Study
During the study period, the predominant variant was Delta and not Omicron
Pfizer CEO says Omicron-targeted vaccine to be ready by March
Bourla said Pfizer could be ready to file for U.S. regulatory approval for a redesigned vaccine and launch it as soon as March
Pfizer confirms COVID pill's results, potency versus omicron
The updates come as COVID-19 cases, deaths and hospitalization are all rising again
Pfizer Covid vaccine provides partial protection against Omicron: Study
The research finding indicated that ACE2 is required for Omicron entry
Mixing other vaccines with AstraZeneca, Pfizer jabs generates robust immune response
The Lancet study found that no safety concerns were raised in the study of 1,070 participants
Moderna says its low-dose COVID shot works for kids 6 to 11
Moderna hasn't yet gotten the go-ahead to offer its vaccine to teens
US opens COVID boosters to all adults, urges them for 50+
Under the new rules, anyone 18 or older can choose either a Pfizer or Moderna booster six months after their last dose
Pfizer results open door to new chapter for COVID-19 treatments
If the drugs are authorized by regulators, they are likely to overtake currently-available antibody treatments
Pfizer vaccine highly effective against Covid hospitalisations for six months: Study
The study underscores the importance of improving COVID-19 vaccination rates worldwide
Pfizer vaccine for kids may not be available until November
The company said Tuesday it provided health regulators with data from a recent study of its vaccine in children 5 to 11 years old